Literature DB >> 17360885

Low serum levels of dehydroepiandrosterone and cortisol in human diffuse cutaneous leishmaniasis by Leishmania mexicana.

Norma Galindo-Sevilla1, Norma Soto, Javier Mancilla, Arturo Cerbulo, Elena Zambrano, Roberto Chavira, Jaime Huerto.   

Abstract

Low levels of dehydroepiandrosterone (DHEA) and cortisol hormones produced by the suprarenal cortex have been associated with diseases involving chronic inflammation, low interferon (IFN)-gamma, and high interleukin (IL)-6. Diffuse cutaneous leishmaniasis (DL), a long-lasting intracellular parasitic infectious disease, can spread unknown levels of DHEA and cortisol. Serum concentrations of both were measured in 5 patients with DL, in 15 patients with localized lesions produced by Leishmania (LL), and in 20 healthy volunteers. Leishmania mexicana mexicana was identified as the causal agent in patients with DL and LL. Hormone levels were lower in DL compared with controls and LL. Furthermore, we detected a lower percentage of IFN-gamma-positive cells with higher levels of IL-6 and higher titers of anti-Leishmania antibodies in patients with DL, whereas patients with LL were similar to controls. These data suggest that patients with DL may be good candidates for DHEA and cortisol supplementation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360885

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Effect of ambient temperature on the clinical manifestations of experimental diffuse cutaneous leishmaniasis in a rodent model.

Authors:  Laura Quiñonez-Díaz; Javier Mancilla-Ramírez; Miroslava Avila-García; Juana Ortiz-Avalos; Angélica Berron; Susana González; Yuriria Paredes; Norma Galindo-Sevilla
Journal:  Vector Borne Zoonotic Dis       Date:  2012-05-31       Impact factor: 2.133

3.  Activity of hydroxyurea against Leishmania mexicana.

Authors:  Hugo Martinez-Rojano; Javier Mancilla-Ramirez; Laura Quiñonez-Diaz; Norma Galindo-Sevilla
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

4.  Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.

Authors:  Henry W Murray
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

5.  NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.

Authors:  Isabel Cristina Cañeda-Guzmán; Norma Salaiza-Suazo; Edith A Fernández-Figueroa; Georgina Carrada-Figueroa; Magdalena Aguirre-García; Ingeborg Becker
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

6.  Characterisation of Casein Kinase 1.1 in Leishmania donovani Using the CRISPR Cas9 Toolkit.

Authors:  Daniel Martel; Tom Beneke; Eva Gluenz; Gerald F Späth; Najma Rachidi
Journal:  Biomed Res Int       Date:  2017-11-29       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.